Pharmacodynamics of Moxifloxacin against Streptococcus pyogenes in an In Vitro Kinetic Model

The aim of the present study was to investigate the pharmacodynamics of moxifloxacin against strains of Streptococcus pyogenes with different susceptibilities to erythromycin by using an in vitro kinetic model simulating human pharmacokinetics of moxifloxacin at oral doses of 400 and 200 mg, respect...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Odenholt, Inga, Löwdin, Elisabeth, Gustafsson, Ingegerd, Cars, Otto
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127214/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12019138/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.6.2046-2048.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!